☆ 4.5 Editorial Material

Advantages and disadvantages of mouse models of chronic lymphocytic leukemia in drug discovery

EXPERT OPINION ON DRUG DISCOVERY (2021)

Get Full Text
Add to Collection

Journal

EXPERT OPINION ON DRUG DISCOVERY
Volume 16, Issue 10, Pages 1085-1090

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/17460441.2021.1935860

Keywords

Chronic lymphocytic leukemia (CLL); patient-derived xenograft (PDX) models; TCL1 mouse model; transgenic mouse models

Categories

Pharmacology & Pharmacy

Funding

  1. Spanish Ministry of Science and Innovation [RTI2018-094584-B-I00]
  2. Centro de Investigacion Biomedica en Red de Cancer (CIBERONC) [CB16/12/00334]
  3. Generalitat de Catalunya [2017 SGR 1009]
  4. Spanish Ministry of Science, Innovation and Universities [FPU19/03110]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.